This is a preview of subscription content, log in via an institution to check access.
Reference
Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim Products. Value in Health : 23 Oct 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.06.014
Rights and permissions
About this article
Cite this article
Claims payments reduced after biosimilar filgrastim launched in US. PharmacoEcon Outcomes News 865, 6 (2020). https://doi.org/10.1007/s40274-020-7230-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7230-6